Table of Content

1 Commercializing Biomarkers Market Overview
1.1 Commercializing Biomarkers Product Scope
1.2 Commercializing Biomarkers Segment by Type
1.2.1 Global Commercializing Biomarkers Sales by Type (2016 & 2021 & 2027)
1.2.2 Consumables
1.2.3 Services
1.2.4 Software
1.3 Commercializing Biomarkers Segment by Application
1.3.1 Global Commercializing Biomarkers Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Neurology
1.3.5 Others
1.4 Commercializing Biomarkers Market Estimates and Forecasts (2016-2027)
1.4.1 Global Commercializing Biomarkers Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Commercializing Biomarkers Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Commercializing Biomarkers Price Trends (2016-2027)

2 Commercializing Biomarkers Estimates and Forecasts by Region
2.1 Global Commercializing Biomarkers Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Commercializing Biomarkers Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Commercializing Biomarkers Sales Market Share by Region (2016-2021)
2.2.2 Global Commercializing Biomarkers Revenue Market Share by Region (2016-2021)
2.3 Global Commercializing Biomarkers Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Commercializing Biomarkers Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Commercializing Biomarkers Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Commercializing Biomarkers Estimates and Projections (2016-2027)
2.4.2 Europe Commercializing Biomarkers Estimates and Projections (2016-2027)
2.4.3 China Commercializing Biomarkers Estimates and Projections (2016-2027)
2.4.4 Japan Commercializing Biomarkers Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Commercializing Biomarkers Estimates and Projections (2016-2027)
2.4.6 India Commercializing Biomarkers Estimates and Projections (2016-2027)

3 Global Commercializing Biomarkers Competition Landscape by Players
3.1 Global Top Commercializing Biomarkers Players by Sales (2016-2021)
3.2 Global Top Commercializing Biomarkers Players by Revenue (2016-2021)
3.3 Global Commercializing Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Commercializing Biomarkers as of 2020)
3.4 Global Commercializing Biomarkers Average Price by Company (2016-2021)
3.5 Manufacturers Commercializing Biomarkers Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Commercializing Biomarkers Market Size by Type
4.1 Global Commercializing Biomarkers Historic Market Review by Type (2016-2021)
4.1.1 Global Commercializing Biomarkers Sales Market Share by Type (2016-2021)
4.1.2 Global Commercializing Biomarkers Revenue Market Share by Type (2016-2021)
4.1.3 Global Commercializing Biomarkers Price by Type (2016-2021)
4.2 Global Commercializing Biomarkers Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Commercializing Biomarkers Sales Forecast by Type (2022-2027)
4.2.2 Global Commercializing Biomarkers Revenue Forecast by Type (2022-2027)
4.2.3 Global Commercializing Biomarkers Price Forecast by Type (2022-2027)

5 Global Commercializing Biomarkers Market Size by Application
5.1 Global Commercializing Biomarkers Historic Market Review by Application (2016-2021)
5.1.1 Global Commercializing Biomarkers Sales Market Share by Application (2016-2021)
5.1.2 Global Commercializing Biomarkers Revenue Market Share by Application (2016-2021)
5.1.3 Global Commercializing Biomarkers Price by Application (2016-2021)
5.2 Global Commercializing Biomarkers Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Commercializing Biomarkers Sales Forecast by Application (2022-2027)
5.2.2 Global Commercializing Biomarkers Revenue Forecast by Application (2022-2027)
5.2.3 Global Commercializing Biomarkers Price Forecast by Application (2022-2027)

6 North America Commercializing Biomarkers Market Facts & Figures
6.1 North America Commercializing Biomarkers Sales by Company
6.1.1 North America Commercializing Biomarkers Sales by Company (2016-2021)
6.1.2 North America Commercializing Biomarkers Revenue by Company (2016-2021)
6.2 North America Commercializing Biomarkers Sales Breakdown by Type
6.2.1 North America Commercializing Biomarkers Sales Breakdown by Type (2016-2021)
6.2.2 North America Commercializing Biomarkers Sales Breakdown by Type (2022-2027)
6.3 North America Commercializing Biomarkers Sales Breakdown by Application
6.3.1 North America Commercializing Biomarkers Sales Breakdown by Application (2016-2021)
6.3.2 North America Commercializing Biomarkers Sales Breakdown by Application (2022-2027)

7 Europe Commercializing Biomarkers Market Facts & Figures
7.1 Europe Commercializing Biomarkers Sales by Company
7.1.1 Europe Commercializing Biomarkers Sales by Company (2016-2021)
7.1.2 Europe Commercializing Biomarkers Revenue by Company (2016-2021)
7.2 Europe Commercializing Biomarkers Sales Breakdown by Type
7.2.1 Europe Commercializing Biomarkers Sales Breakdown by Type (2016-2021)
7.2.2 Europe Commercializing Biomarkers Sales Breakdown by Type (2022-2027)
7.3 Europe Commercializing Biomarkers Sales Breakdown by Application
7.3.1 Europe 142 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 142 Sales Breakdown by Application (2022-2027)

8 China Commercializing Biomarkers Market Facts & Figures
8.1 China Commercializing Biomarkers Sales by Company
8.1.1 China Commercializing Biomarkers Sales by Company (2016-2021)
8.1.2 China Commercializing Biomarkers Revenue by Company (2016-2021)
8.2 China Commercializing Biomarkers Sales Breakdown by Type
8.2.1 China Commercializing Biomarkers Sales Breakdown by Type (2016-2021)
8.2.2 China Commercializing Biomarkers Sales Breakdown by Type (2022-2027)
8.3 China Commercializing Biomarkers Sales Breakdown by Application
8.3.1 China 161 Sales Breakdown by Application (2016-2021)
8.3.2 China 161 Sales Breakdown by Application (2022-2027)

9 Japan Commercializing Biomarkers Market Facts & Figures
9.1 Japan Commercializing Biomarkers Sales by Company
9.1.1 Japan Commercializing Biomarkers Sales by Company (2016-2021)
9.1.2 Japan Commercializing Biomarkers Revenue by Company (2016-2021)
9.2 Japan Commercializing Biomarkers Sales Breakdown by Type
9.2.1 Japan Commercializing Biomarkers Sales Breakdown by Type (2016-2021)
9.2.2 Japan Commercializing Biomarkers Sales Breakdown by Type (2022-2027)
9.3 Japan Commercializing Biomarkers Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Commercializing Biomarkers Market Facts & Figures
10.1 Southeast Asia Commercializing Biomarkers Sales by Company
10.1.1 Southeast Asia Commercializing Biomarkers Sales by Company (2016-2021)
10.1.2 Southeast Asia Commercializing Biomarkers Revenue by Company (2016-2021)
10.2 Southeast Asia Commercializing Biomarkers Sales Breakdown by Type
10.2.1 Southeast Asia Commercializing Biomarkers Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Commercializing Biomarkers Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Commercializing Biomarkers Sales Breakdown by Application
10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)

11 India Commercializing Biomarkers Market Facts & Figures
11.1 India Commercializing Biomarkers Sales by Company
11.1.1 India Commercializing Biomarkers Sales by Company (2016-2021)
11.1.2 India Commercializing Biomarkers Revenue by Company (2016-2021)
11.2 India Commercializing Biomarkers Sales Breakdown by Type
11.2.1 India Commercializing Biomarkers Sales Breakdown by Type (2016-2021)
11.2.2 India Commercializing Biomarkers Sales Breakdown by Type (2022-2027)
11.3 India Commercializing Biomarkers Sales Breakdown by Application
11.3.1 India Commercializing Biomarkers Sales Breakdown by Application (2016-2021)
11.3.2 India Commercializing Biomarkers Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Commercializing Biomarkers Business
12.1 Roche
12.1.1 Roche Corporation Information
12.1.2 Roche Business Overview
12.1.3 Roche Commercializing Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Roche Commercializing Biomarkers Products Offered
12.1.5 Roche Recent Development
12.2 Dako (Agilent Technologies)
12.2.1 Dako (Agilent Technologies) Corporation Information
12.2.2 Dako (Agilent Technologies) Business Overview
12.2.3 Dako (Agilent Technologies) Commercializing Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Dako (Agilent Technologies) Commercializing Biomarkers Products Offered
12.2.5 Dako (Agilent Technologies) Recent Development
12.3 Merck
12.3.1 Merck Corporation Information
12.3.2 Merck Business Overview
12.3.3 Merck Commercializing Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Merck Commercializing Biomarkers Products Offered
12.3.5 Merck Recent Development
12.4 BD
12.4.1 BD Corporation Information
12.4.2 BD Business Overview
12.4.3 BD Commercializing Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.4.4 BD Commercializing Biomarkers Products Offered
12.4.5 BD Recent Development
12.5 Abbott
12.5.1 Abbott Corporation Information
12.5.2 Abbott Business Overview
12.5.3 Abbott Commercializing Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Abbott Commercializing Biomarkers Products Offered
12.5.5 Abbott Recent Development
12.6 Genesys Biolabs (20/20GeneSystems)
12.6.1 Genesys Biolabs (20/20GeneSystems) Corporation Information
12.6.2 Genesys Biolabs (20/20GeneSystems) Business Overview
12.6.3 Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers Products Offered
12.6.5 Genesys Biolabs (20/20GeneSystems) Recent Development
12.7 Affymetrix
12.7.1 Affymetrix Corporation Information
12.7.2 Affymetrix Business Overview
12.7.3 Affymetrix Commercializing Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Affymetrix Commercializing Biomarkers Products Offered
12.7.5 Affymetrix Recent Development
12.8 Agendia
12.8.1 Agendia Corporation Information
12.8.2 Agendia Business Overview
12.8.3 Agendia Commercializing Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Agendia Commercializing Biomarkers Products Offered
12.8.5 Agendia Recent Development
12.9 ALMAC
12.9.1 ALMAC Corporation Information
12.9.2 ALMAC Business Overview
12.9.3 ALMAC Commercializing Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.9.4 ALMAC Commercializing Biomarkers Products Offered
12.9.5 ALMAC Recent Development
12.10 Arrayit
12.10.1 Arrayit Corporation Information
12.10.2 Arrayit Business Overview
12.10.3 Arrayit Commercializing Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Arrayit Commercializing Biomarkers Products Offered
12.10.5 Arrayit Recent Development
12.11 Biocartic
12.11.1 Biocartic Corporation Information
12.11.2 Biocartic Business Overview
12.11.3 Biocartic Commercializing Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Biocartic Commercializing Biomarkers Products Offered
12.11.5 Biocartic Recent Development
12.12 BG Medicine
12.12.1 BG Medicine Corporation Information
12.12.2 BG Medicine Business Overview
12.12.3 BG Medicine Commercializing Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.12.4 BG Medicine Commercializing Biomarkers Products Offered
12.12.5 BG Medicine Recent Development
12.13 KEGG EXPRESSION Database
12.13.1 KEGG EXPRESSION Database Corporation Information
12.13.2 KEGG EXPRESSION Database Business Overview
12.13.3 KEGG EXPRESSION Database Commercializing Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.13.4 KEGG EXPRESSION Database Commercializing Biomarkers Products Offered
12.13.5 KEGG EXPRESSION Database Recent Development
12.14 Thermo Fisher
12.14.1 Thermo Fisher Corporation Information
12.14.2 Thermo Fisher Business Overview
12.14.3 Thermo Fisher Commercializing Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Thermo Fisher Commercializing Biomarkers Products Offered
12.14.5 Thermo Fisher Recent Development
12.15 BGI
12.15.1 BGI Corporation Information
12.15.2 BGI Business Overview
12.15.3 BGI Commercializing Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.15.4 BGI Commercializing Biomarkers Products Offered
12.15.5 BGI Recent Development

13 Commercializing Biomarkers Manufacturing Cost Analysis
13.1 Commercializing Biomarkers Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Commercializing Biomarkers
13.4 Commercializing Biomarkers Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Commercializing Biomarkers Distributors List
14.3 Commercializing Biomarkers Customers

15 Market Dynamics
15.1 Commercializing Biomarkers Market Trends
15.2 Commercializing Biomarkers Drivers
15.3 Commercializing Biomarkers Market Challenges
15.4 Commercializing Biomarkers Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Commercializing Biomarkers Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Commercializing Biomarkers Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Commercializing Biomarkers Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Commercializing Biomarkers Sales (K MT) by Region (2016-2021)
Table 5. Global Commercializing Biomarkers Sales Market Share by Region (2016-2021)
Table 6. Global Commercializing Biomarkers Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Commercializing Biomarkers Revenue Share by Region (2016-2021)
Table 8. Global Commercializing Biomarkers Sales (K MT) Forecast by Region (2022-2027)
Table 9. Global Commercializing Biomarkers Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Commercializing Biomarkers Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Commercializing Biomarkers Revenue Share Forecast by Region (2022-2027)
Table 12. Global Commercializing Biomarkers Sales (K MT) of Key Companies (2016-2021)
Table 13. Global Commercializing Biomarkers Sales Share by Company (2016-2021)
Table 14. Global Commercializing Biomarkers Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Commercializing Biomarkers Revenue Share by Company (2016-2021)
Table 16. Global Commercializing Biomarkers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Commercializing Biomarkers as of 2020)
Table 17. Global Commercializing Biomarkers Average Price (USD/MT) of Key Company (2016-2021)
Table 18. Manufacturers Commercializing Biomarkers Manufacturing Sites and Area Served
Table 19. Manufacturers Commercializing Biomarkers Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Commercializing Biomarkers Sales (K MT) by Type (2016-2021)
Table 22. Global Commercializing Biomarkers Sales Share by Type (2016-2021)
Table 23. Global Commercializing Biomarkers Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Commercializing Biomarkers Price (USD/MT) by Type (2016-2021)
Table 25. Global Commercializing Biomarkers Sales Share by Type (2022-2027)
Table 26. Global Commercializing Biomarkers Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Commercializing Biomarkers Revenue Share by Type (2022-2027)
Table 28. Global Commercializing Biomarkers Price (USD/MT) by Type (2022-2027)
Table 29. Global Commercializing Biomarkers Sales (K MT) by Application (2016-2021)
Table 30. Global Commercializing Biomarkers Sales Share by Application (2016-2021)
Table 31. Global Commercializing Biomarkers Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Commercializing Biomarkers Price (USD/MT) by Application (2016-2021)
Table 33. Global Commercializing Biomarkers Sales (K MT) by Application (2022-2027)
Table 34. Global Commercializing Biomarkers Sales Share by Application (2022-2027)
Table 35. Global Commercializing Biomarkers Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Commercializing Biomarkers Revenue Share by Application (2022-2027)
Table 37. Global Commercializing Biomarkers Price (USD/MT) by Application (2022-2027)
Table 38. North America Commercializing Biomarkers Sales (K MT) by Company (2016-2021)
Table 39. North America Commercializing Biomarkers Sales Market Share by Company (2016-2021)
Table 40. North America Commercializing Biomarkers Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Commercializing Biomarkers Revenue Market Share by Company (2016-2021)
Table 42. North America Commercializing Biomarkers Sales by Type (2016-2021) & (K MT)
Table 43. North America Commercializing Biomarkers Sales Market Share by Type (2016-2021)
Table 44. North America Commercializing Biomarkers Sales by Type (2022-2027) & (K MT)
Table 45. North America Commercializing Biomarkers Sales Market Share by Type (2022-2027)
Table 46. North America Commercializing Biomarkers Sales by Application (2016-2021) & (K MT)
Table 47. North America Commercializing Biomarkers Sales Market Share by Application (2016-2021)
Table 48. North America Commercializing Biomarkers Sales by Application (2022-2027) & (K MT)
Table 49. North America Commercializing Biomarkers Sales Market Share by Application (2022-2027)
Table 50. Europe Commercializing Biomarkers Sales (K MT) by Company (2016-2021)
Table 51. Europe Commercializing Biomarkers Sales Market Share by Company (2016-2021)
Table 52. Europe Commercializing Biomarkers Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Commercializing Biomarkers Revenue Market Share by Company (2016-2021)
Table 54. Europe Commercializing Biomarkers Sales by Type (2016-2021) & (K MT)
Table 55. Europe Commercializing Biomarkers Sales Market Share by Type (2016-2021)
Table 56. Europe Commercializing Biomarkers Sales by Type (2022-2027) & (K MT)
Table 57. Europe Commercializing Biomarkers Sales Market Share by Type (2022-2027)
Table 58. Europe Commercializing Biomarkers Sales by Application (2016-2021) & (K MT)
Table 59. Europe Commercializing Biomarkers Sales Market Share by Application (2016-2021)
Table 60. Europe Commercializing Biomarkers Sales by Application (2022-2027) & (K MT)
Table 61. Europe Commercializing Biomarkers Sales Market Share by Application (2022-2027)
Table 62. China Commercializing Biomarkers Sales (K MT) by Company (2016-2021)
Table 63. China Commercializing Biomarkers Sales Market Share by Company (2016-2021)
Table 64. China Commercializing Biomarkers Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Commercializing Biomarkers Revenue Market Share by Company (2016-2021)
Table 66. China Commercializing Biomarkers Sales by Type (2016-2021) & (K MT)
Table 67. China Commercializing Biomarkers Sales Market Share by Type (2016-2021)
Table 68. China Commercializing Biomarkers Sales by Type (2022-2027) & (K MT)
Table 69. China Commercializing Biomarkers Sales Market Share by Type (2022-2027)
Table 70. China Commercializing Biomarkers Sales by Application (2016-2021) & (K MT)
Table 71. China Commercializing Biomarkers Sales Market Share by Application (2016-2021)
Table 72. China Commercializing Biomarkers Sales by Application (2022-2027) & (K MT)
Table 73. China Commercializing Biomarkers Sales Market Share by Application (2022-2027)
Table 74. Japan Commercializing Biomarkers Sales (K MT) by Company (2016-2021)
Table 75. Japan Commercializing Biomarkers Sales Market Share by Company (2016-2021)
Table 76. Japan Commercializing Biomarkers Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Commercializing Biomarkers Revenue Market Share by Company (2016-2021)
Table 78. Japan Commercializing Biomarkers Sales by Type (2016-2021) & (K MT)
Table 79. Japan Commercializing Biomarkers Sales Market Share by Type (2016-2021)
Table 80. Japan Commercializing Biomarkers Sales by Type (2022-2027) & (K MT)
Table 81. Japan Commercializing Biomarkers Sales Market Share by Type (2022-2027)
Table 82. Japan Commercializing Biomarkers Sales by Application (2016-2021) & (K MT)
Table 83. Japan Commercializing Biomarkers Sales Market Share by Application (2016-2021)
Table 84. Japan Commercializing Biomarkers Sales by Application (2022-2027) & (K MT)
Table 85. Japan Commercializing Biomarkers Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Commercializing Biomarkers Sales (K MT) by Company (2016-2021)
Table 87. Southeast Asia Commercializing Biomarkers Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Commercializing Biomarkers Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Commercializing Biomarkers Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Commercializing Biomarkers Sales by Type (2016-2021) & (K MT)
Table 91. Southeast Asia Commercializing Biomarkers Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Commercializing Biomarkers Sales by Type (2022-2027) & (K MT)
Table 93. Southeast Asia Commercializing Biomarkers Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Commercializing Biomarkers Sales by Application (2016-2021) & (K MT)
Table 95. Southeast Asia Commercializing Biomarkers Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Commercializing Biomarkers Sales by Application (2022-2027) & (K MT)
Table 97. Southeast Asia Commercializing Biomarkers Sales Market Share by Application (2022-2027)
Table 98. India Commercializing Biomarkers Sales (K MT) by Company (2016-2021)
Table 99. India Commercializing Biomarkers Sales Market Share by Company (2016-2021)
Table 100. India Commercializing Biomarkers Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Commercializing Biomarkers Revenue Market Share by Company (2016-2021)
Table 102. India Commercializing Biomarkers Sales by Type (2016-2021) & (K MT)
Table 103. India Commercializing Biomarkers Sales Market Share by Type (2016-2021)
Table 104. India Commercializing Biomarkers Sales by Type (2022-2027) & (K MT)
Table 105. India Commercializing Biomarkers Sales Market Share by Type (2022-2027)
Table 106. India Commercializing Biomarkers Sales by Application (2016-2021) & (K MT)
Table 107. India Commercializing Biomarkers Sales Market Share by Application (2016-2021)
Table 108. India Commercializing Biomarkers Sales by Application (2022-2027) & (K MT)
Table 109. India Commercializing Biomarkers Sales Market Share by Application (2022-2027)
Table 110. Roche Corporation Information
Table 111. Roche Description and Business Overview
Table 112. Roche Commercializing Biomarkers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 113. Roche Commercializing Biomarkers Product
Table 114. Roche Recent Development
Table 115. Dako (Agilent Technologies) Corporation Information
Table 116. Dako (Agilent Technologies) Description and Business Overview
Table 117. Dako (Agilent Technologies) Commercializing Biomarkers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 118. Dako (Agilent Technologies) Commercializing Biomarkers Product
Table 119. Dako (Agilent Technologies) Recent Development
Table 120. Merck Corporation Information
Table 121. Merck Description and Business Overview
Table 122. Merck Commercializing Biomarkers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 123. Merck Commercializing Biomarkers Product
Table 124. Merck Recent Development
Table 125. BD Corporation Information
Table 126. BD Description and Business Overview
Table 127. BD Commercializing Biomarkers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 128. BD Commercializing Biomarkers Product
Table 129. BD Recent Development
Table 130. Abbott Corporation Information
Table 131. Abbott Description and Business Overview
Table 132. Abbott Commercializing Biomarkers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 133. Abbott Commercializing Biomarkers Product
Table 134. Abbott Recent Development
Table 135. Genesys Biolabs (20/20GeneSystems) Corporation Information
Table 136. Genesys Biolabs (20/20GeneSystems) Description and Business Overview
Table 137. Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 138. Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers Product
Table 139. Genesys Biolabs (20/20GeneSystems) Recent Development
Table 140. Affymetrix Corporation Information
Table 141. Affymetrix Description and Business Overview
Table 142. Affymetrix Commercializing Biomarkers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 143. Affymetrix Commercializing Biomarkers Product
Table 144. Affymetrix Recent Development
Table 145. Agendia Corporation Information
Table 146. Agendia Commercializing Biomarkers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 147. Agendia Description and Business Overview
Table 148. Agendia Commercializing Biomarkers Product
Table 149. Agendia Recent Development
Table 150. ALMAC Corporation Information
Table 151. ALMAC Commercializing Biomarkers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 152. ALMAC Description and Business Overview
Table 153. ALMAC Commercializing Biomarkers Product
Table 154. ALMAC Recent Development
Table 155. Arrayit Corporation Information
Table 156. Arrayit Description and Business Overview
Table 157. Arrayit Commercializing Biomarkers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 158. Arrayit Commercializing Biomarkers Product
Table 159. Arrayit Recent Development
Table 160. Biocartic Corporation Information
Table 161. Biocartic Description and Business Overview
Table 162. Biocartic Commercializing Biomarkers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 163. Biocartic Commercializing Biomarkers Product
Table 164. Biocartic Recent Development
Table 165. BG Medicine Corporation Information
Table 166. BG Medicine Description and Business Overview
Table 167. BG Medicine Commercializing Biomarkers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 168. BG Medicine Commercializing Biomarkers Product
Table 169. BG Medicine Recent Development
Table 170. KEGG EXPRESSION Database Corporation Information
Table 171. KEGG EXPRESSION Database Description and Business Overview
Table 172. KEGG EXPRESSION Database Commercializing Biomarkers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 173. KEGG EXPRESSION Database Commercializing Biomarkers Product
Table 174. KEGG EXPRESSION Database Recent Development
Table 175. Thermo Fisher Corporation Information
Table 176. Thermo Fisher Description and Business Overview
Table 177. Thermo Fisher Commercializing Biomarkers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 178. Thermo Fisher Commercializing Biomarkers Product
Table 179. Thermo Fisher Recent Development
Table 180. BGI Corporation Information
Table 181. BGI Description and Business Overview
Table 182. BGI Commercializing Biomarkers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 183. BGI Commercializing Biomarkers Product
Table 184. BGI Recent Development
Table 185. Production Base and Market Concentration Rate of Raw Material
Table 186. Key Suppliers of Raw Materials
Table 187. Commercializing Biomarkers Distributors List
Table 188. Commercializing Biomarkers Customers List
Table 189. Commercializing Biomarkers Market Trends
Table 190. Commercializing Biomarkers Market Drivers
Table 191. Commercializing Biomarkers Market Challenges
Table 192. Commercializing Biomarkers Market Restraints
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
List of Figures
Figure 1. Commercializing Biomarkers Product Picture
Figure 2. Global Commercializing Biomarkers Sales Market Share by Type in 2021 & 2027
Figure 3. Consumables Product Picture
Figure 4. Services Product Picture
Figure 5. Software Product Picture
Figure 6. Global Commercializing Biomarkers Sales Market Share by Application in 2021 & 2027
Figure 7. Oncology Examples
Figure 8. Cardiology Examples
Figure 9. Neurology Examples
Figure 10. Others Examples
Figure 11. Global Commercializing Biomarkers Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Commercializing Biomarkers Sales Growth Rate (2016-2027) & (US$ Million)
Figure 13. Global Commercializing Biomarkers Sales (K MT) Growth Rate (2016-2027)
Figure 14. Global Commercializing Biomarkers Price Trends Growth Rate (2016-2027) (USD/MT)
Figure 15. Global Commercializing Biomarkers Revenue Market Share by Region: 2016 VS 2021
Figure 16. Global Commercializing Biomarkers Revenue Market Share by Region: 2021 VS 2027
Figure 17. North America Commercializing Biomarkers Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. North America Commercializing Biomarkers Sales (K MT) Growth Rate (2016-2027)
Figure 19. Europe Commercializing Biomarkers Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. Europe Commercializing Biomarkers Sales (Million USD) Growth Rate (2016-2027)
Figure 21. China Commercializing Biomarkers Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. China Commercializing Biomarkers Sales (Million USD) and Growth Rate (2016-2027)
Figure 23. Japan Commercializing Biomarkers Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Japan Commercializing Biomarkers Sales (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Commercializing Biomarkers Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. Southeast Asia Commercializing Biomarkers Sales (Million USD) Growth Rate (2016-2027)
Figure 27. India Commercializing Biomarkers Revenue (Million USD) Growth Rate (2016-2027)
Figure 28. India Commercializing Biomarkers Sales (Million USD) Growth Rate (2016-2027)
Figure 29. Global 5 Largest Commercializing Biomarkers Players Market Share by Revenue in Commercializing Biomarkers: 2016 & 2020
Figure 30. Commercializing Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 31. Global Commercializing Biomarkers Revenue Share by Type (2016-2021)
Figure 32. Global Commercializing Biomarkers Revenue Growth Rate by Type in 2016 & 2020
Figure 33. Global Commercializing Biomarkers Revenue Share by Application (2016-2021)
Figure 34. Global Commercializing Biomarkers Revenue Growth Rate by Application in 2016 & 2020
Figure 35. North America Commercializing Biomarkers Sales Market Share by Type in 2020
Figure 36. North America Commercializing Biomarkers Sales Market Share by Application in 2020
Figure 37. Europe Commercializing Biomarkers Sales Market Share by Type in 2020
Figure 38. Europe Commercializing Biomarkers Sales Market Share by Application in 2020
Figure 39. China Commercializing Biomarkers Sales Market Share by Type in 2020
Figure 40. China Commercializing Biomarkers Sales Market Share by Application in 2020
Figure 41. Japan Commercializing Biomarkers Sales Market Share by Type in 2020
Figure 42. Japan Commercializing Biomarkers Sales Market Share by Application in 2020
Figure 43. Southeast Asia Commercializing Biomarkers Sales Market Share by Type in 2020
Figure 44. Southeast Asia Commercializing Biomarkers Sales Market Share by Application in 2020
Figure 45. India Commercializing Biomarkers Sales Market Share by Type in 2020
Figure 46. India Commercializing Biomarkers Sales Market Share by Application in 2020
Figure 47. Key Raw Materials Price Trend
Figure 48. Manufacturing Cost Structure of Commercializing Biomarkers
Figure 49. Manufacturing Process Analysis of Commercializing Biomarkers
Figure 50. Commercializing Biomarkers Industrial Chain Analysis
Figure 51. Channels of Distribution
Figure 52. Distributors Profiles
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed